China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition

MT Newswires Live

2025/02/07

China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.

The deal involves purchasing shares from seven entities.

The transaction is subject to board and shareholder approvals.

Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2509765996"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509765996\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509765996?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-07 13:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509765996","market":"hk","top_or_hot":-1,"title":"China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition","media":"MT Newswires Live","content":"<html><body><p> China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.</p><p>The deal involves purchasing shares from seven entities.</p><p>The transaction is subject to board and shareholder approvals.</p><p>Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Sanjiu Gets SASAC Approval for Tasly Pharmaceutical Stake Acquisition\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-02-07 13:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.</p><p>The deal involves purchasing shares from seven entities.</p><p>The transaction is subject to board and shareholder approvals.</p><p>Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0185","symbol_name":"二線龍頭","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509765996","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509765996","pubTimestamp":1738907237,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Sanjiu  received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group , according to filings with the Shanghai and Shenzhen bourses.The deal involves purchasing shares from seven entities.The transaction is subject to board and shareholder approvals.Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600535":"天士力","BK0185":"二线龙头","BK0183":"MSCI概念","BK0010":"央企","BK0188":"融资融券","BK0239":"医药制造","BK0012":"证金概念","BK0196":"行业龙头","BK0175":"白马股","BK0060":"抗癌","000999":"华润三九","BK0028":"国家队"},"translate_title":"华润三九天士力药业股权收购获国资委批复","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600535":0.9,"000999":0.9},"content_text":"China Resources Sanjiu (SHE:000999) received approval from China's State-owned Assets Supervision and Administration Commission for its acquisition of shares in Tasly Pharmaceutical Group (SHA:600535), according to filings with the Shanghai and Shenzhen bourses.The deal involves purchasing shares from seven entities.The transaction is subject to board and shareholder approvals.Shares of China Resources Sanjiu rose 2% in recent trade on the Shenzhen bourse, while those of Tasly Pharmaceutical climbed 1% on the Shanghai bourse.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}